Offer - Urjas Oil for just ₹ 1 X
Olmetime H 40 Tablet is a prescription medicine that is available as a Tablet. Other than this, Olmetime H 40 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Olmetime H 40 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Olmetime H 40 Tablet also has some side effects, the most common being Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmetime H 40 Tablet as well, which are listed below. These side effects of Olmetime H 40 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Olmetime H 40 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Olmetime H 40 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Asthma, Allergy, Kidney Disease must refrain from the use of Olmetime H 40 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Olmetime H 40 Tablet are listed in the contraindications section below.
Drug reaction of Olmetime H 40 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Olmetime H 40 Tablet is considered not safe while driving, and is not addictive.
Olmetime H 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmetime H 40 Tablet safe for pregnant women?
Olmetime H shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmetime H 40 Tablet safe during breastfeeding?
Olmetime H may have very limited harmful effects for breastfeeding women.
What is the effect of Olmetime H 40 Tablet on the Kidneys?
Very few cases of side effects of Olmetime H on kidney have been reported.
What is the effect of Olmetime H 40 Tablet on the Liver?
Olmetime H has very mild side effects on the liver.
What is the effect of Olmetime H 40 Tablet on the Heart?
Very few cases of side effects of Olmetime H on the heart have been reported.
Olmetime H 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmetime H 40 Tablet unless your doctor advises you to do so -
Is this Olmetime H 40 Tablet habit forming or addictive?
No, you will not get addicted to Olmetime H 40 Tablet.
Interaction between Food and Olmetime H 40 Tablet
Some foods when eaten with Olmetime H 40 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmetime H 40 Tablet
Taking Olmetime H 40 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173